GMX-101

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameGMX-101

Drug Alias NameGelRPEallogeneiciPSC-derivedRPEcell therapy (GelMEDIX),GMX-101

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Retinal stem cell therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsGeographic Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGelMEDIX Inc

China Registration ClassN/A

Develop Information

Active CompaniesGelMEDIX Inc

Inactive CompaniesN/A

Active IndicationsGeographic Atrophy

Inactive IndicationsN/A

Other Information

ATC CodeN/A